ICM
AVA icon

Invenomic Capital Management’s Avista AVA Stock Holding History

Invenomic Capital Management’s Portfolio AVA Stock Details AVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-235,920
Closed -$9.09M – 153
2025
Q4 		$9.09M Buy
235,920
+50,410
+27% +$1.97M 0.42% 78
2025
Q3 		$7.01M Buy
+185,510
New +$6.9M 0.34% 85
2024
Q4 		– Sell
-275,741
Closed -$10.7M – 161
2024
Q3 		$10.7M Sell
275,741
-54,842
-17% -$2.07M 0.59% 63
2024
Q2 		$11.4M Buy
330,583
+100,126
+43% +$3.58M 0.56% 61
2024
Q1 		$8.07M Buy
230,457
+91,668
+66% +$3.12M 0.43% 76
2023
Q4 		$4.96M Buy
+138,789
New +$4.7M 0.23% 109

Other funds holding AVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Invenomic Capital Management's AVA Position: Q1 2026 in Review

Invenomic Capital Management sold out of Avista (AVA) in Q1 2026, closing a stake of 235,920 shares — an estimated $9.09M sold.

Invenomic Capital Management first reported a position in AVA in Q4 2023 and held it in 6 quarters. The position peaked at $11.4M in Q2 2024. 403 funds tracked by Wall St. Rank hold AVA as of Q1 2026.

  • Invenomic Capital Management reported no remaining Avista position as of Q1 2026 after selling out during the quarter.
  • Invenomic Capital Management sold 235,920 Avista shares in Q1 2026, an estimated $9.09M.
  • Invenomic Capital Management first reported a position in Avista in Q4 2023 and held it in 6 quarters.
  • Invenomic Capital Management's Avista position peaked at $11.4M in Q2 2024.
  • 403 funds tracked by Wall St. Rank held Avista as of Q1 2026.

Based on Invenomic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.